The anthrax vaccine adsorbed vaccine generates protective antigen (PA)-specific CD4+ T cells with a phenotype distinct from that of naïve PA T cells

Infection and Immunity

Volumn 76, Issue 10, 2008, Pages 4538-4545

  Kwok, William W ^a,b   Yang, Junbao ^a   James, Eddie ^a   Bui, John ^a   Huston, Laurie ^a   Wiesen, Andrew R ^c   Roti, Michelle ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE; CD45RA ANTIGEN; CYTOKINE; TETRAMER;

ARTICLE; CD4+ T LYMPHOCYTE; CELL LINEAGE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; EX VIVO STUDY; FEASIBILITY STUDY; HUMAN; HUMAN CELL; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VACCINATION;

ANTHRAX VACCINES; ANTIGENS, BACTERIAL; ANTIGENS, CD45; BACTERIAL TOXINS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNOLOGIC MEMORY; LEUKOCYTES, MONONUCLEAR; T-LYMPHOCYTE SUBSETS;

EID: 53649105577     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00324-08     Document Type: Article

References (26)

1. Allen, J. S., A. Skowera, G. J. Rubin, S. Wessely, and M. Peakman. 2006. Long-lasting T cell responses to biological warfare vaccines in human vaccinees. Clin. Infect. Dis. 43:1-7.
2. Baillie, L., T. Townend, N. Walker, U. Eriksson, and D. Williamson. 2004. Characterization of the human immune response to the UK anthrax vaccine. FEMS Immunol. Med. Microbiol. 42:267-270.
3. Barnard, J. P., and A. M. Friedlander. 1999. Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen. Infect. Immun. 67:562-567.
4. Cieslak, T. J., and E. M. Eitzen, Jr. 1999. Clinical and epidemiologic principles of anthrax. Emerg. Infect. Dis. 5:552-555.
5. Cohen, S., I. Mendelson, Z. Altboum, D. Kobiler, E. Elhanany, T. Bino, M. Leitner, I. Inbar, H. Rosenberg, Y. Gozes, R. Barak, M. Fisher, C. Kronman, B. Velan, and A. Shafferman. 2000. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect. Immun. 68:4549-4558.
6. Danke, N. A., and W. W. Kwok. 2003. HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination. J. Immunol. 171:3163-3169.
7. Grabenstein, J. D. 2003. Anthrax vaccine: a review. Immunol. Allergy Clin. North Am. 23:713-730.
8. Grunow, R., M. Porsch-Ozcurumez, W. Splettstoesser, A. Buckendahl, U. Hahn, W. Beyer, R. Bohm, M. Huber, U. vd Esche, W. Bessler, D. Frangoulidis, and E. J. Finke. 2007. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine. Vaccine 25:3679-3683.
9. Hanson, J. F., S. C. Taft, and A. A. Weiss. 2006. Neutralizing antibodies and persistence of immunity following anthrax vaccination. Clin. Vaccine Immunol. 13:208-213.
10. Kim, C. H., L. Rott, E. J. Kunkel, M. C. Genovese, D. P. Andrew, L. Wu, and E. C. Butcher. 2001. Rules of chemokine receptor association with T cell polarization in vivo. J. Clin. Investig. 108:1331-1339.
11. Kyriacou, D. N., A. Adamski, and N. Khardori. 2006. Anthrax: from antiquity and obscurity to a front-runner in bioterrorism. Infect. Dis. Clin. North Am. 20:227-251.
12. + T cells recognize epitopes of protective antigen following vaccination with an anthrax vaccine. Infect. Immun. 75:1852-1860.
13. Lininger, L. A., M. E. Cullum, M. B. Lyles, and D. R. Bienek. 2007. The impact of incomplete vaccination schedules on the magnitude and duration of protective antigen-specific IgG responses in recipients of the US licensed anthrax vaccine. Vaccine 25:1619-1625.
14. Lucas, M., C. L. Day, J. R. Wyer, S. L. Cunliffe, A. Loughry, A. J. McMichael, and P. Klenerman. 2004. Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells. J. Virol. 78:7284-7287.
15. Marcus, H., R. Danieli, E. Epstein, B. Velan, A. Shafferman, and S. Reuveny. 2004. Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine. Infect. Immun. 72:3471-3477.
16. Mock, M., and A. Fouet. 2001. Anthrax. Annu. Rev. Microbiol. 55:647-671.
17. Novak, E. J., A. W. Liu, G. T. Nepom, and W. W. Kwok. 1999. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J. Clin. Investig. 104:R63-R67.
18. Novak, E. J., A. W. Liu, J. A. Gebe, B. A. Falk, G. T. Nepom, D. M. Koelle, and W. W. Kwok. 2001. Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens. J. Immunol. 166:6665-6670.
19. Pittman, P. R., S. L. Norris, J. G. Barrera Oro, D. Bedwell, T. L. Cannon, and K. T. McKee, Jr. 2006. Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series. Vaccine 24:3654-3660.
20. Reuveny, S., M. D. White, Y. Y. Adar, Y. Kafri, Z. Altboum, Y. Gozes, D. Kobiler, A. Shafferman, and B. Velan. 2001. Search for correlates of protective immunity conferred by anthrax vaccine. Infect. Immun. 69:2888-2893.
21. Rivino, L., M. Messi, D. Jarrossay, A. Lanzavecchia, F. Sallusto, and J. Geginat. 2004. Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J. Exp. Med. 200:725-735.
22. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22:745-763.
23. Scorpio, A., T. E. Blank, W. A. Day, and D. J. Chabot. 2006. Anthrax vaccines: Pasteur to the present. Cell. Mol. Life Sci. 63:2237-2248.
24. Shinn, A. H., N. C. Bravo, H. T. Maecker, and J. W. Smith. 2003. TNF-alpha detection using a flow cytometric assay to determine cellular responses to anthrax vaccine. J. Immunol. Methods 282:169-174.
25. Turnbull, P. C., M. G. Broster, J. A. Carman, R. J. Manchee, and J. Melling. 1986. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infect. Immun. 52:356-363.
26. Welkos, S., S. Little, A. Friedlander, D. Fritz, and P. Fellows. 2001. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147:1677-1685.